Article
Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms.
Seminars in liver disease - 1 Feb 2018
Lalazar Gadi, Simon Sanford M
Abstract excerpt
Fibrolamellar hepatocellular carcinoma (FLC) is a rare form of primary liver cancer that affects adolescents and young adults without underlying liver disease. Surgery remains the mainstay of therapy; however, most patients are either not surgical candidates or suffer from recurrence. There is no approved systemic therapy and the overall survival remains poor. Historically classified as a subtype of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
